Genentech takes the health and safety of our patients, customers, employees and local communities very seriously, and we are actively responding to the global COVID-19 pandemic. For more, please visit our COVID-19 response page.

Genentech at ASCO 2012

May 30th, 2012

Genentech to report progress at the American Society of Clinical Oncology

Genentech will present important new data from studies of several cancer medicines at the 48th Annual Meeting of the American Society of Clinical Oncology (ASCO) from June 1-5, 2012, in Chicago.

This page is intended to be a media resource for Genentech developments at ASCO. It will be updated frequently throughout the meeting.


Related news releases

New Data on Important Progress for People with Advanced Cancers (5/15/2012)

Medicine Reduced Risk of a Difficult-to-Treat Ovarian Cancer From Getting Worse (6/1/2012)

Pivotal Trial of Investigational Breast Cancer Medicine Showed Reduced Risk of Cancer Worsening (6/2/2012)

Metastatic Colorectal Cancer Medicine Helped People Live Longer (6/2/2012)

Fact Sheets

 


Inside the Research: Gene Expressions Video Series

Watch interviews with Genentech scientists to better understand our innovative approach to research.

 

By The Numbers

30
Oral Presentations at the meeting
3
Studies in the press briefing
2
Medicines in the plenary